As shown in Figure 3C, cluster 2 was significantly enriched in the upper pathways of graft-versus-host disease, systemic lupus erythematosus, allograft rejection, type I diabetes mellitus and intestinal immune network for IgA production. This evidence concerns the gene CD79A and graft versus host disease.